Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice

Neurosci Res. 2005 Jan;51(1):111-5. doi: 10.1016/j.neures.2004.09.012.

Abstract

The present study was undertaken to examine whether 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes damage of dopaminergic glomerular cells of the olfactory bulb (OB) in C57BL/6 mice. At 3 days after MPTP treatment, dopamine level in the striatum and the OB decreased to 13% and 84% of the control mice, respectively. While a small reduction of tyrosine hydroxylase protein level was observed in the OB of MPTP-treated mice, dopamine transporter (DAT) was undetectable at the protein level in this region. These results indicate that the DAT protein level could account for resistance of the OB to the Parkinsonism-inducing toxin.

Publication types

  • Comparative Study

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Blotting, Western / methods
  • Corpus Striatum / drug effects*
  • Dopamine / metabolism
  • Dopamine Agents / pharmacology*
  • Dopamine Plasma Membrane Transport Proteins
  • Homovanillic Acid / metabolism
  • Immunohistochemistry / methods
  • Male
  • Membrane Glycoproteins / metabolism
  • Membrane Transport Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nerve Tissue Proteins / metabolism
  • Olfactory Bulb / drug effects*
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Dopamine Agents
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Slc6a3 protein, mouse
  • 3,4-Dihydroxyphenylacetic Acid
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase
  • Sodium-Potassium-Exchanging ATPase
  • Dopamine
  • Homovanillic Acid